摘要
目的比较曲安奈德与复方倍他米松治疗肱骨外上髁炎的临床效果。方法选择80例肱骨外上髁炎患者(共87侧)参加该研究,分为曲安奈德封闭组(40例患者,43侧)和复方倍他米松封闭组(40例患者,44侧);分别进行曲安奈德封闭和复方倍他米松封闭治疗,并观察、评价其临床效果。结果曲安奈德组、复方倍他米松组治疗前后视觉模拟评分(VAS)明显降低、日常生活活动(ADL)评分明显升高;复方倍他米松组治疗前后VAS评分差值(改善程度)较曲安奈德组明显增大(P<0.01);复方倍他米松组治疗前后ADL评分差值(改善程度)较曲安奈德组明显增大(P<0.01)。结论曲安奈德与复方倍他米松封闭治疗对肱骨外上髁炎均有效,但复方倍他米松封治疗疗效优于曲安奈德。
Objective To compare the clinical treatment effect of triamcinolone acetonide and compound betamethasone in treating humeral external epicondylitis. Methods Eighty patients with humeral external epicondylitis were selected,87 sides participated in this clinical research,and divided into the triamcinolone acetonide blocking group(40 cases,43 sides) and compound beta- methasone blocking group (40 cases,44 sides). Then the two groups received triamcinolone acetonide or compound betamethasone blocking therapy respectively. The clinical treatment effects were observed and evaluated. Results The Visual Analogue Scale (VAS) score after treatment in the triamcinolone acetonide group and compound betamethasone group was obviously decreased compared with before treatment (P〈0.01), the Activities of Daily Living(ADL)score was obviously increased (P〈0.01);The difference value (improvement degree) of VAS score before and after treatment in the compound betamethasone group was obviously increased compared with the triamcinolone acetonide group (P〈0.01). Conclusion Both triamcinolone acetonide and compound betamethasone blocking treatment are effective on humeral external epicondylitis, but the curative effect of compound betamethasone is superior to that of triamcinolone acetonide.
出处
《重庆医学》
CAS
北大核心
2017年第25期3526-3528,共3页
Chongqing medicine
基金
国家自然科学基金青年基金资助项目(81301573)
重庆市自然科学基金资助项目(cstc2013jcyjA10090)
关键词
曲安奈德
复方倍他米松
肱骨外上髁炎
triamcinolone acetonide
compound betamethasone
humeral external epicondylitis